Future studies will focus on exploring the applicability of using Nr1d1 gene delivery for treating Nr2e3-associated retinal degeneration at advanced stages of disease, as well as retinal disease with other genetic causes. The gene discussed is NR2E3; the disease is retinal degeneration.